Relaxivity of Hydrogen Protons of Water Molecules in the Aqueous Solutions of Dextran - and Chitosan - Coated Ferrite Nanoparticles

Similar documents
Available online at ScienceDirect. Procedia Materials Science 11 (2015 )

Chapter 6 Magnetic nanoparticles

Interaction of Gold Nanoparticle with Proteins

Superparamagnetic Iron Oxide Nanoparticles For Drug Delivery

Part III: Sequences and Contrast

Control of the Saturation Temperature in Magnetic Heating by Using Polyethylene-glycol-coated Rod-shaped Nickel-ferrite (NiFe 2 O 4 ) Nanoparticles

IRON OXIDE NANOPARTICLES FOR BIOMEDICAL APPLICATIONS

Supporting Information. Sol gel Coating of Inorganic Nanostructures with Resorcinol Formaldehyde Resin

PREPARATION AND MAGNETIC PROPERTIES INVESTIGATION OF Fe 3 O 4 NANOPARTICLES 99m Tc LABELED AND Fe 3 O 4 NANOPARTICLES DMSA COATED

STRUCTURE AND MAGNETIC PROPERTIES OF SiO 2 COATED Fe 2 NANOPARTICLES SYNTHESIZED BY CHEMICAL VAPOR CONDENSATION PROCESS

O-Allylation of phenols with allylic acetates in aqueous medium using a magnetically separable catalytic system

NANOMEDICINE. WILEY A John Wiley and Sons, Ltd., Publication DESIGN AND APPLICATIONS OF MAGNETIC NANOMATERIALS, NANOSENSORS AND NANOSYSTEMS

Superparamagnetic nanoparticle arrays for magnetically tunable photonics. Josh Kurzman Materials 265

Supporting Information

Preparation of Fe 3 O 2 Nanostructures via Inverse Micelle Method and Study of Their Magnetic Properties for Biological Applications

Synthesis and Characterization of Superparamagnetic Iron Oxide Nanoparticles for Water Purification Applications

MAGNETIC NANOPARTICLES FOR HYPERTHERMIA APPLICATIONS. Mohamed DARWISH and Ivan STIBOR

The Basics of Magnetic Resonance Imaging

Gold Nanoparticles Functionalized with Gadolinium Chelates as High Relaxivity MRI Contrast Agents.

Magnetic Nano Particles for In-Vitro Diagnostics

ANTIBIOTIC COATED MAGNETITE NANOPARTICLES FOR BIOLOGICAL APPLICATIONS

An investigation on the optimum conditions of synthesizing a magnetite based ferrofluid as MRI contrast agent using Taguchi method

magnetic micro- and nanoparticles

Magnetically-driven selective synthesis of Au clusters on Fe 3 O 4 Nanoparticles

Supporting Information

Development of NIR Bioimaging Systems

Synthesis of Uniform Hollow Oxide Nanoparticles. through Nanoscale Acid Etching

Double Mesoporous Silica Shelled Spherical/Ellipsoidal Nanostructures: Synthesis and Hydrophilic/Hydrophobic Anticancer Drug Delivery

A Hydrophilic/Hydrophobic Janus Inverse-Opal

Chapter 2 Magnetic Properties

Use of Silica and Iron-Oxide Nanoparticles with Specific Surface Coatings for Enhanced Oil Recovery

Supporting information. Bioinspired synthesis of gadolinium-based hybrid nanoparticles as. MRI blood pool contrast agents with high relaxivity

Intrinsic Viscosity and Unperturbed Dimension of Poly(DL-lactic acid) Solution

Permeable Silica Shell through Surface-Protected Etching

Synthesis of 12 nm iron oxide nanoparticles

ABSTRACT I. INTRODUCTION II. BACKGROUND OF STUDY

Formation and Surface Modification of Fe 3 O 4 Nanoparticles by Co-precipitation and Sol-gel Method

The Preparation of Gold Magnetic Nanoparticles Through Layer-by- Layer Assembly Technique

Nanobiotechnology. Place: IOP 1 st Meeting Room Time: 9:30-12:00. Reference: Review Papers. Grade: 40% midterm, 60% final report (oral + written)

Polarised Nucleon Targets for Europe, 2nd meeting, Bochum 2005

ECE Lecture #8 ECE 5320

Adsorption and desorption of lysozyme on thermosensitive nano-sized magnetic particles and its conformational changes

Characterization of partially reduced graphene oxide as room

External Magnetic Field Enhanced Chemo-Photothermal Combination Tumor. Therapy via Iron Oxide Nanoparticles

Surface Modification of PTMS Particles with Organosilanes: TEOS-, VTMS-, and MTMS-Modified Particles

In today s lecture, we will cover:

Utilization of Rice Husk Ash Silica in Controlled Releasing Application

International Journal of Chemistry and Pharmaceutical Sciences

Mat. Res. Soc. Symp. Proc. Vol Materials Research Society

Supplementary Information

Chapter 11 Properties of Solutions

Chemistry 104 Final Exam Content Evaluation and Preparation for General Chemistry I Material

Understanding Aqueous Dispersibility of Graphene Oxide and Reduced Graphene Oxide through pka Measurements

International Journal of Scientific & Engineering Research, Volume 5, Issue 3, March-2014 ISSN

Synthesis and Characterization of Iron-Oxide (Hematite) Nanocrystals. Z.H. Lee

Supporting Information

Seminars in Nanosystems - I

Role of Surface Charge of Inhibitors on Amyloid Beta Fibrillation

Supporting Information

Hydrophilic Superparamagnetic Iron Oxide Nanoparticles. What s Next in the MRI Contrast Agents Arena? Giorgio Zoppellaro

Supplementary Figure 1 A schematic representation of the different reaction mechanisms

A Systematic Study of the Synthesis of Silver Nanoplates: Is Citrate a. "Magic" Reagent?

Mn 12 Single-Molecule Magnet Aggregates as Magnetic Resonance Imaging Contrast Agents

Supplementary Figure 1. Schematic layout of set-up for operando NMR studies.

A Simple and Green Method for Synthesis of Ag and Au Nanoparticles Using Biopolymers and Sugars as Reducing Agents.

Magnetic Nanoparticles: A Review of Chemical and Physical Characteristics Important in Medical Applications

Q1. As the world population increases there is a greater demand for fertilisers.

NANOPARTICLES USING AMPHIPHILIC POLYSILOXANE GRAFT COPOLYMERIC

Supporting Information. for. Advanced Materials, adma Wiley-VCH 2006

Chapter 7 MAGNETIC RESONANCE IMAGING (MRI) STUDIES OF MODIFIED MESOPOROUS SILICA

SPM ( ) NANOBRICK CO., Ltd o

Magnetic Resonance Imaging. Qun Zhao Bioimaging Research Center University of Georgia

Applying the Taguchi Method to Optimise the Size of Silica Nanoparticles Entrapped with Rifampicin for a Drug Delivery System

Processing and Applications of Carbon Nanotubes, Graphene, and Beyond

The Biological Effect of Iron Oxide and its Hydrate Nanoparticles

Supporting information

High Frequency sonoatrp of 2-Hydroxyethyl Acrylate in an Aqueous Medium

II. The physico-chemical properties of proteins

High-Purity Separation of Gold Nanoparticle Dimers and Trimers

Probing the Kinetics of Ligand Exchange on Colloidal Gold. Nanoparticles by Surface-Enhanced Raman Scattering

Lec.1 Chemistry Of Water

Simulations of Self-Assembly of Polypeptide-Based Copolymers

Surface Engineering of g-maghemite (Fe 2 O 3 ) Nanoparticles Process Optimization Using Design Of Experiments (DoE) for sirna-mediated Gene Silencing

SUPPORTING INFORMATION

INTERACTION BETWEEN DRUGS AND BIOMEDICAL MATERIALS. I. BINDING POSITION OF BEZAFIBRATE TO HUMAN SERUM ALUBMIN

Supporting Information

Controlled Synthesis of MFe 2 O 4 (M = Mn, Fe, Co, Ni and Zn) Nanoparticles and Their Magnetic Properties.

Time-Dependent Statistical Mechanics 1. Introduction

SYNTHESIS AND CHARACTERIZATION OF TITANIUM METAL CARBON NANO TUBES

Electronic supplementary information

Supporting Information

The Dielectric Properties of (PVA-PEG-PVP-MgO) and (PVA-PEG-PVP-CoO) Biomaterials

Three Dimensional Nano-assemblies of Noble Metal. Nanoparticles-Infinite Coordination Polymers as a Specific

A project report on SYNTHESIS AND CHARACTERISATION OF COPPER NANOPARTICLE-GRAPHENE COMPOSITE. Submitted by Arun Kumar Yelshetty Roll no 410 CY 5066

Multifunctional plasmonic nanoparticles for biomedical applications

Supporting Information.

Lecture #7 In Vivo Water

Jahresbericht 2003 der Arbeitsgruppe Experimentalphysik Prof. Dr. Michael Farle

A dual redox-responsive supramolecular amphiphile fabricated by selenium-containing pillar[6]arene-based molecular recognition

ENVIRONMENTAL PROTECTION OF CHEMICAL INDUSTRY

Transcription:

ISSN 1749-8023 (print), 1749-8031 (online) International Journal of Magnetic Resonance Imaging Vol. 01, No. 01, 2007, pp. 015-020 Relaxivity of Hydrogen Protons of Water Molecules in the Aqueous Solutions of Dextran - and Chitosan - Coated Ferrite Nanoparticles Sungwook Hong and Ilsu Rhee + Department of Physics, Kyungpook National University, Daegu, Korea (Received 10 September 2006, accepted 1 December 2006) Abstract. Ferrite nanoparticles were synthesized at around 4 ~25 and coated during the synthesis process with biocompatible and biodegradable polymers, dextran or chitosan. The size of ferrite nanoparticles was determined to be 7.51nm by DLS (Dynamic Light Scattering) and TEM (Transmission Electron Microscope). The size of coated nanoparticles was increased up to 128.6nm and 67nm for dextran and chitosan coating, respectively. The relaxivity of T 1 and T 2 of hydrogen proton of water molecule in the aqueous solution of both uncoated and coated nanoparticles were found to be linear with the concentration of nanoparticles in the solution. We found that the relaxivity of hydrogen protons in the solution of coated nanoparticles are much faster (50 to 60 times) than those in the solution of uncoated nanoparticles. Keywords: ferrite nanoparticles, dextran coating, citosan coating, relaxivity. 1. Introduction Recently, along with the development of technologies that enable the manipulation of the shape and size of nanomaterial, their application to the medical field is attracting great interest. Especially, the development of contrast agents for MRI (Magnetic Resonance Imaging), which is widely used in noninvasive diagnosis, is of great interest. Gd (Gadolinium), the paramagnetic material currently used for contrast agents, is not suitable for biological use in its bare state. In order to negate its toxicity that induces cellular dechelation, Gd is usually coupled with ligands such as DTPA and used in a chelated state. As an alternative, Fe (iron) [1] is under development, since it is a stronger magnet and has a stronger influence on the magnetic relaxation time, especially the T 2. For the Fe-ferrite (Fe 3 O 4 ) nanoparticle to be used as a contrast agent, it needs to have the properties of a super-paramagnet which is achievable by making the size of nanoparticles smaller than a few tens of nanometer [2]. Also, since it is extremely toxic in its bare state, it needs to be coated with biocompatible polymers. Other conditions include absence of side effects, maintenance of chemical stability in the human body, and the excretion from the body in an appropriate amount of time. Several nano-sized ferrite particle synthesis methods, which involve the use of Fe + + 2 and Fe 3 in room temperature, exist [3-9]. The polymer materials used for coating are PCL (poly-ε-caprolactone), PLA (poly lactide), copolymer [10] of PCL and PLA, dextran [11, 12], chitosan [13], and so on. Dextran and chitosan are hydrophilic, biodegradable, and biocompatible. Especially, chitosan is non-antigenic, non-toxic, and biofunctional, making it an ideal polymer for biological application [14-15]. In our study, synthesis of ferrite, Fe 3 O 4, and the coating of it with biocompatible polymer such as dextran and chitosan were executed simultaneously at 4 ~25 and approximately ph 7, in the neutral state; this method is similar to the one used for coating ferrite with tripsin [9], which is an enzyme. We studied the relaxation time of the protons of water molecules surrounding the nanoparticles, which were dissolved in water. More specifically, the effect of two factors on the relaxation time was studied: the concentration of nanoparticles and the absence/presence of polymer coating. Results showed that both 1/T 1 and 1/T 2 were linearly dependent on the nanoparticle concentration. Polymer coating significantly reduced the effect of nanoparticles on T 1 and T 2. + Corresponding author. E-mail address: ilrhee@knu.ac.kr. Published by World Academic Union (World Academic Press)

16 2. Experiment S. Hong, et al.: Relaxivity of Hydrogen Protons of Water Molecules The coating of ferrite nanoparticles with dextran (SIGMA, Average mol wt 68,800) was performed simultaneously with the synthesis of the ferrite particles. The experimental setup for these processes is shown in Fig.1. 10ml of 0.15M iron chloride aqueous solution (FeCl 2 +FeCl 3 ) and 20ml of 2% (w/w) dextran solution were mixed together. When air bubbles were introduced into this mixture by using a pipette, some of the Fe +2 ions were oxidized to Fe +3 ions, and Fe 3 O 4 particles were synthesized. The dextran in the mixture adhered to the particles, but most biocompatible materials, including dextran, were coated stably on ferrite surfaces only when a near neutral ph condition was met. Thus, we adjusted the amount of added NH 4 OH solution so that the ph value of the mixture maintained a value of around 7. The coating process was performed inside an ice water bath [7]. The oxidation of iron due to an oversupply of oxygen by the air jet was eliminated at low temperature of about 4. Otherwise, when the coating processes were performed at room temperature, a precipitate of iron oxide was observed at the bottom of the cylinder. Fig.1: The schematic figure of the experimental setup for synthesizing and coating the ferrite nanoparticles simultaneously is shown here. The dextran coating processes are performed inside the ice water bath at around 4 and the chitosan coating processes are performed at room temperature. 1% (w/v) chitosan (ALDRICH, low molecular weight, Brookfield viscosity 20.000cps) solution was made by dissolving 0.2g of chitosan in 19ml of water with 1ml of 2N Acetic acid solution (SIGMA). The coating of ferrite nanoparticles with chitosan was performed simultaneously with the synthesis of the ferrite particles by mixing 15ml of the diluted 0.05% chitosan solution with 0.5ml of 0.5M iron chloride solution. The process of coating with chitosan was basically the same as that of dextran coating except the iron bath was not used. The reason for this is that the colloid state of coated particles is not maintained due to high viscosity of chitosan at low temperature. Dextran coating is formed by hydro-bonding of the carboxy group (COOH - ) of dextran to the oxygen atom of Fe 3 O 4. On the other hand, the hydro-bonding of the hydroxyl group (OH - ) of chitosan to the oxygen atom of Fe 3 O 4 results in the coating of chitosan on the particles. The OSO 3 - and NH 2 - groups exist on the opposite sides of the hydro-bonding for dextran and chitosan coatings, respectively. Thus, any organic solvent or surfactant is not necessary to maintain the colloidal state in the solution of coated particles [14, 16]. Int JMRI email for submitting: editor@jmri.org.uk

International Journal of Magnetic Resonance Imaging, Vol. 01 (2007) No. 01, pp 015-020 17 The synthesis of bare ferrite nanoparticles and their physical properties were already described in detail elsewhere [17]. The size distribution of particles was measured by the DLS (Dynamic Lighting Scattering) method. This is shown in Fig.2. The mean diameter of bare particle was about 7.51nm. On the other hand, the mean diameters of coated particles were increased to 128.6nm and 67nm for dextran and chitosan coatings, respectively. TEM (Transmission Electron Microscope) was used to check how well the coating was formed. This is shown in Fig.3. In the dextran coating, aggregated ferrite particles showed a diameter of about 100nm. On the other hand, separated bare ferrites of a few nm were observed in chitosan coating. Fig.2: The size distribution of nanoparticles in an aqueous solution by using dynamic light scattering spectrometer is shown in this figure. The mean diameters of the bare (a), chitosan coated (b), and dextran coated (c) ferrite particles are about 7.51nm, 67.0nm, and 128.6nm, respectively. Fig.3: The transmission electron microscope images of the bare (left), dextran coated (center), and chitosan coated (right) ferrite particle are shown here. We can see in this figure that the dextran and chitosan are well coated on the entire surface of ferrite particles. Int JMRI email for subscription: publishing@wau.org.uk

18 3. Results and Discussion S. Hong, et al.: Relaxivity of Hydrogen Protons of Water Molecules The T 1 and T 2 relaxation times of hydrogen protons of water molecules in ferrite nanoparticle solutions at various concentrations were measured using the nuclear magnetic resonance spectrometer (Bruker Advance Digital 400, 400MHz, T 1 : Inversion Recovery T 2 : CPMG). In the solutions, the T 1 and T 2 of the hydrogen protons of water molecules are influenced by the surrounding magnetic iron-ferrite particles, and the relaxation times become shorter than those in pure water (Both the T 1 and T 2 have the same value of about 4 sec in pure water). The spin-lattice relaxation time, T 1 is mainly related to the energy transfer between hydrogen protons and their surroundings. On the other hand, the spin-spin relaxation time, T 2 is related to the dephasing process of the spin vectors of the hydrogen protons. In MRI, the reduction of relaxation times due to the paramagnetic materials in the contrast agent results in the decrease of MR (Magnetic Resonance) signal, and consequently increases the image contrast. Especially, super-paramagnetic materials like nano-sized ferrite have a very high magnetic susceptibility, and thus generate a large local magnetic field which accelerates the dephasing process of the spin vectors of the hydrogen protons. Consequently, the ferrite based contrast agent will give us a very good contrast in the T 2 weighted image. The T 1m and T 2m of hydrogen protons in an aqueous solution of magnetic particles are related to the T 1 and T 2 in pure water as [18-19] 1/T im =1/T i +R ic (1) where i=1 or 2, R i 's denote the relaxivities of T i 's of hydrogen protons, and C represents the concentration of particles homogeneously distributed in aqueous solution. The plots of 1/T im versus C for both bare and coated ferrite particles are shown in Fig.4. Fig.4: The plots of T 1 versus C for both bare and coated ferrite particles are shown here. The plot for the coated ferrite is blown up as an inset for clarity. We can see in Fig.4 that the linear dependence of T 1 relaxation rate for both dextran and chitosan coatings are well preserved. The slopes (relaxivities) are 0.07897, 0.00333, and 0.00291 [1/s-ppm] for the Int JMRI email for submitting: editor@jmri.org.uk

International Journal of Magnetic Resonance Imaging, Vol. 01 (2007) No. 01, pp 015-020 19 bare, dextran- and chitosan-coated particles, respectively. We can see that the T 1 relaxivity for the bare ferrite particles is decreased by a factor of about 1/23 and 1/27 for the dextran- and chitosan-coated particles, respectively. This result is consistent with our expectation. The distance between the water molecules and the core ferrite of coated particles is much larger than the distance between the bare ferrite and water molecules. Consequently, the relaxivity for the coated ferrite becomes much smaller than that for the bare ferrite. A slightly larger relaxivity for the dextran coating reflects the fact that the aggregated dextran-coated particles shown in Fig.3 generate a slightly larger local magnetic field fluctuation than the dispersed chitosan-coated nanoparticle. The T 2 relaxivities are determined to be 3.7544, 0.07223, and 0.0619 [1/s-ppm] for the bare, dextran- and chitosan-coated particles, respectively (Fig.5). Thus, we can see that T 2 relaxivities for the dextran and chitosan coatings are decreased by a factor of about 1/52 and 1/61, respectively. This means that T 2 is influenced much more by the coating of ferrite nanoparticles than T 1. The reason for this is that T 2 is more sensitive to the magnetic inhomogeneity than T 1. To achieve the maximum effect of contrast agent on T 2, the ferrites should be coated as thinly as possible, since the interaction between magnetic particles and water molecules depends on their distance. The ratio of T 2 to T 1 relaxivity for the bare particle is about 50. This ratio is reduced to about 21 for both dextran- and chitosan-coated particles. Thus, we can see that the change of T 2 relaxivity according to the particle concentration is much greater for both the bare and coated particles. Consequently, we can see that the MRI contrast agent using ferrite superparamagnetic particles is much more effective for the T 2 weighted image than for the T 1 weighted image. Fig.5: The plots of T 2 versus C for both bare and coated ferrite particles are shown here. The plot for the coated ferrite is blown up as an inset for clarity. Using our results, we will be able to formulate the relationship between the changes of relaxation times of hydrogen protons and the magnetic particle concentration injected into an experimental body. These outputs will help us develop MRI contrast agents based on magnetic nanoparticles. Animal experiments with coated ferrite solution as an MRI contrast agent are now under way. We hope that a systematic relationship between the concentration of ferrite nanoparticle and the contrast of MRI imaging is obtained. This will let us develop MRI contrast agents whose relaxation times are controllable by adjusting the concentration of magnetic particles. Int JMRI email for subscription: publishing@wau.org.uk

20 4. References S. Hong, et al.: Relaxivity of Hydrogen Protons of Water Molecules [1] J. W. M. Bulte, and D. L. Kraitchman, Iron oxide MR contrast agents for molecular and cellular imaging, NMR Biomed., 17, 2004, pp.484-499. [2] T. Sato, T. Ijima, M. Seki, and N. Inagaki, Magnetic properties of ultrafine ferrite particles, J. Magn. Magn. Mater, 65, 1987, pp.252-256. [3] O. P. Perez, Y. Umetsu, and H. Sasaki, Precipitation and densification of magnetic iron compounds from aqueous solutions at room temperature, Hydrometallurgy, 50, 1998, pp.223-242. [4] N. Feltin, and M. P. Pileni, New technique for synthesizing iron ferrite magnetic nanosized particles, Langmuir, 13, 1997, pp.3927-3933. [5] P. A. Dresco, V. S. Zaitsey, R. J. Gambino, and B. Chu, Preparation and properties of magnetite and polymer magnetite nanoparticles, Langmuir, 15, 1999, pp.1945-1951. [6] B. Denizot, C. Tanguy, F. Hindre, E. Rump, J. Lejeune, and P. Jallet, Phosphorylcholine coating of iron oxide nanoparticles, J. Colloid Interface Sci., 209, 1999, pp.66-71. [7] D. Portet, B. Denizot, E. Rump, J. Lejeune, and P. Jallet, Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents, J. Colloid Interface Sci., 238, 2001, pp.37-42. [8] M. Tada, S. Hatanaka, H. Sanbonsugi, N. Matsushita, and M. Abe, Method for synthesizing ferrite nanoparticles ~30 nm in diameter on neutral ph condition for biomedical applications, J. Appl. Phys., 93, 2003, pp.7566-7568. [9] K. Nishimura, M. Hasegawa, Y.Ogura, T.NiShi, K. Kataoka, and H. Handa, 4 C preparation of ferrite nanoparticles having protein molecules immobilized on their surfaces, J. Appl. Phys., 91, 2002, pp.8555-8556. [10] Y. Hu, X. Jiang, Y. Ding, H. Ge, Y. Yuan, and C. Yang, Synthesis and characterization of chitosan poly (acrylic acid) nanoparticles, Biomaterials, 23, 2003, pp.3193-3201. [11] C. C. Berry, S. Wells, S. Charles, and A. S. G. Crutis, Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro, Biomaterials, 24, 2003, pp.4551-4557. [12] L. M. Lacava, Z. G. M. Lacava, M. F. Da Silva, O. Dilva, S. B. Chaves, R. B. Azebedo, et al., Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice, Bio-Physical Journal, 80, 2001, pp.2483-2496. [13] Q. Chen, Y. Hu, Y. Chen, X. Jiang, and Y. Yang, Microstructure formation and property of chitosan-poly (acrylic acid) nanoparticles prepared by macromolecular complex, Macromol. Biosci., 5, 2005, pp.993-1000. [14] W. B. Tan, and Y. Zhang, Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications, J. Biomed. Mater. Res., 75A, 2005, pp. 56-62. [15] Y. Chen, V. J. Mohanraj, and J. E. Parkin, Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide, Letters in Peptide Science, 10, 2003, pp.621-627. [16] M. Tang, H. Dou, and K. Sun, One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly, Polymer, 47, 2006, pp.728-734. [17] Ilsu Rhee, and C. Kim, The concentration dependence of relaxation times of hydrogen proton in the aqueous solution of iron ferrite magnetic nanoparticles, J. Magn. Magn. Mat., 261, 2003, pp.410-414. [18] A. Bjornerud, L. Johansson, and NMR Biomed, The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system, 17, 2004, pp.465-477. [19] Y. Okuhata, Delivery of diagnostic agents for magnetic resonance imaging, Adv. Drug Delivery Rev., 37, 1999, pp.121-137. Int JMRI email for submitting: editor@jmri.org.uk